NCCN Patient Webinar: Basal Cell Skin Cancer

Join experts as they provide information and answer questions about basal cell skin cancer to help patients and caregivers compare, discuss, and select treatment options with their doctor.

Topics Discussed:
00:00 - Welcome and Introductions
02:00 - What is Basal Cell Carcinoma?
05:20 - Risk Factors
08:56 - Signs and Symptoms
10:50 - Diagnosis
11:45 - Staging
14:09 - Treatment and Prevention
18:58 - Clinical Trials
19:34 - Hedgehog Pathway Inhibitors
22:28 - PD-1 Blockade with Cemiplimab
26:25 - Prevention
27:14 - Management of Common Side Effects
36:25 - What is Advocacy and Ways to Get Involved
40:45 - Question & Answer Session
1:00:17 - Closing Remarks

Question & Answer Session
40:50 - What is Basosquamous Cancer?
41:59 - What role does cryosurgery play?
43:03 - What total daily dosage is recommended for Nicotinamide B3? What role does Vitamin B3 play in prevention? How can you discuss with your doctor?
44:57 - What should be included in a yearly skin exam?
46:47 - What are the recommendations for patients positive for lynch syndrome?
47:31 - Does liquid nitrogen ever have a place in early treatment?
48:33 - How do you balance decisions and getting second opinions?
50:43 - Why is Vitamin B3 not recommended for people who are immunosuppressed?
51:42 - If Basal Cell Cancer becomes metastatic, where is it most likely to metastasize?
52:31 - Are there any topical medications available to treat Basal Cell Skin Cancer?
53:51 - Daily dosing for Nicotinamide (Vitamin B3)
54:07 - Are there other supplements you can take to reduce the chances of developing Basal Cell Carcinoma?
55:16 - What portion of those with Basal Cell Skin Cancer develop another within 5 years?
55:56 - How do you know if you have a "good" dermatologist?
59:40 - Do actinic keratosis (AKs) ever become basal cell carcinoma?

The Patient Webinar: Basal Cell Skin Cancer occurred in May 2022. This informational program was created in conjunction with the recently updated NCCN Guidelines for Patients® for Basal Cell Skin Cancer (https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=60).

The NCCN Guidelines for Patients are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee.

NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician.

Supporters:
This webinar is supported through the NCCN Foundation, by contributions from our corporate supporters: Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.
________________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit http://www.nccn.org/patients/foundation
________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.

Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCNvideo?sub_confirmation=1

Connect with us!
Twitter: https://twitter.com/NCCN
LinkedIn: https://www.linkedin.com/company/nccn/
Facebook: https://www.facebook.com/NCCNorg
Instagram: https://www.instagram.com/NCCNorg/